Author Correction: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells (Nature Communications, (2015), 6, 1, (8271), 10.1038/ncomms9271);PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells

Nature Communications

Volumn 6, Issue , 2015, Pages

  Han, Haibo ^a   Du, Yantao ^a   Zhao, Wei ^a   Li, Sheng ^a   Chen, Dongji ^a   Zhang, Jing ^b   Liu, Jiang ^b   Suo, Zhenhe ^c   Bian, Xiuwu ^d   Xing, Baocai ^a   Zhang, Zhiqian ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b Chinese Academy of Sciences   (China)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; MICRORNA; MICRORNA 200B; MICRORNA 222; MICRORNA 424; MICRORNA LET 7C; NOTCH3 RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PBX3; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL ALPHA2DELTA1; CACNA2D1 PROTEIN, HUMAN; CALCIUM CHANNEL; HOMEODOMAIN PROTEIN; MIRN200 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; MIRN424 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN; ONCOPROTEIN; PROTO-ONCOGENE PROTEIN PBX3;

ANATOMY; CALCIUM; CARCINOGEN; CELLS AND CELL COMPONENTS; GENE EXPRESSION; PHENOTYPE; RNA; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR INITIATING CELL; TUMOR MICROENVIRONMENT; APOPTOSIS; CANCER STEM CELL; CELL PROLIFERATION; CYTOLOGY; FEMALE; GENETICS; LIVER; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; CALCIUM CHANNELS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS;

EID: 84942849452     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-019-10052-z     Document Type: Erratum

References (64)

1. Clarke, M. F. et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339-9344 (2006).
2. Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313-319 (2011).
3. Visvader, J. E., Lindeman, G. J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717-728 (2012).
4. Frank, N. Y., Schatton, T., Frank, M. H. The therapeutic promise of the cancer stem cell concept. J. Clin. Invest. 120, 41-50 (2010).
5. De Vito, C. et al. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in ewing sarcoma. Cancer Cell 21, 807-821 (2012).
6. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
7. Riggi, N. et al. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev. 24, 916-932 (2010).
8. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009).
9. Liu, Y. et al. Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell 4, 336-347 (2009).
10. He, G. et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384-396 (2013).
11. Chang, C.-J. et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 13, 317-U296 (2011).
12. Chaffer, C. L. et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74 (2013).
13. Chaffer, C. L. et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl Acad. Sci. USA 108, 7950-7955 (2011).
14. Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583-594 (2010).
15. Ivey, K. N., Srivastava, D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 7, 36-41 (2010).
16. Tay, Y., Zhang, J., Thomson, A. M., Lim, B., Rigoutsos, I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124-1128 (2008).
17. Marson, A. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521-533 (2008).
18. Wang, Y., Medvid, R., Melton, C., Jaenisch, R., Blelloch, R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell selfrenewal. Nat. Genet. 39, 380-385 (2007).
19. Liu, C., Tang, D. G. MicroRNA regulation of cancer stem cells. Cancer Res. 71, 5950-5954 (2011).
20. DeSano, J. T., Xu, L. MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J. 11, 682-692 (2009).
21. Ma, S. et al. miR-130b Promotes CD133(\+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 7, 694-707 (2010).
22. Ji, J. et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50, 472-480 (2009).
23. Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
24. Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211-215 (2011).
25. Bu, P. et al. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 12, 602-615 (2013).
26. Yin, G. et al. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29, 3545-3553 (2010).
27. Saini, S. et al. miRNA-708 control of CD44(\+) prostate cancer-initiating cells. Cancer Res. 72, 3618-3630 (2012).
28. Fareh, M. et al. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell. Death Differ. 19, 232-244 (2012).
29. Xu, X. L. et al. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. Carcinogenesis 31, 167-174 (2010).
30. Zhao, W. et al. 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel a2d1 subunit. Cancer Cell 23, 541-556 (2013).
31. Sainz, B., Heeschen, C. Standing out from the crowd: cancer stem cells in hepatocellular carcinoma. Cancer Cell 23, 431-433 (2013).
32. Haraguchi, T., Ozaki, Y., Iba, H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucl. Acid Res. 37, e43 (2009).
33. Dweep, H., Sticht, C., Pandey, P., Gretz, N. miRWalk-database: prediction of possible miRNA binding sites by 'walking' the genes of three genomes. J. Biomed. Inform. 44, 839-847 (2011).
34. Laurent, A., Bihan, R., Omilli, F., Deschamps, S., Pellerin, I. PBX proteins: much more than Hox cofactors. Int. J. Dev. Biol. 52, 9-20 (2008).
35. Li, Z. et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood 121, 1422-1431 (2013).
36. Han, H. B. et al. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J. Pathol. 226, 544-555 (2012).
37. Li, Z. et al. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood 119, 2314-2324 (2012).
38. Yamashita, T. et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136, 1012-1024 (2009).
39. Yang, Z. F. et al. Significance of CD90\+ cancer stem cells in human liver cancer. Cancer Cell 13, 153-166 (2008).
40. Hou, J. et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232-243 (2011).
41. Dhayat, S. A. et al. The microRNA-200 family-a potential diagnostic marker in hepatocellular carcinoma? J. Surg. Oncol. 110, 430-438 (2014).
42. Wong, Q. W. et al. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin. Cancer Res. 16, 867-875 (2010).
43. Li, W. et al. GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proc. Natl Acad. Sci. USA 111, 1521-1526 (2014).
44. Lin, J. et al. Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1. PLoS ONE 9, e98418 (2014).
45. Li, C., Liu, V. W., Chiu, P. M., Chan, D. W., Ngan, H. Y. Over-expressions of AMPK subunits in ovarian carcinomas with significant clinical implications. BMC Cancer 12, 357 (2012).
46. Liu, C. et al. Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Res. 72, 3393-3404 (2012).
47. Xu, J. et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32, 976-987 (2013).
48. Pallasch, C. P. et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 114, 3255-3264 (2009).
49. Izumiya, M., Okamoto, K., Tsuchiya, N., Nakagama, H. Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs. Carcinogenesis 31, 1354-1359 (2010).
50. Felli, N. et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl Acad. Sci. USA 102, 18081-18086 (2005).
51. le Sage, C. et al. Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26, 3699-3708 (2007).
52. Pineau, P. et al. miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl Acad. Sci. USA 107, 264-269 (2010).
53. Peter, M. E. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 29, 2161-2164 (2010).
54. Li, Y. et al. PBX3 is overexpressed in gastric cancer and regulates cell proliferation. Tumour Biol. 35, 4363-4368 (2014).
55. Papagiannakopoulos, T. et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 31, 1884-1895 (2012).
56. Zeisig, B. B. et al. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol. Cell Biol. 24, 617-628 (2004).
57. Lin, Y. W., Aplan, P. D. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Leukemia 21, 1276-1284 (2007).
58. Novak, R. L. et al. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp. Hematol. 40, 1016-1027 (2012).
59. Wong, P., Iwasaki, M., Somervaille, T. C. P., So, C. W. E., Cleary, M. L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21, 2762-2774 (2007).
60. Li, H., Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
61. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
62. Quinlan, A. R., Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
63. Lan, L. et al. Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis. Int. J. Cancer 126, 53-64 (2010).
64. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).